China Jiuhao Health Industry Corporation Limited announced that Mr. Zhang Changsheng has resigned a an executive Director and the vice chairman of the Company; Mr. Tian Suning, Edward has resigned as a non-executive Director of the Company and Mr. Hugo Shong has resigned a non-executive Director of the Company, all with effect from 5 February 2016. The Board has proposed three nominees of Huayi Brothers, namely Mr. Wang Zhongjun, Mr. Wang Zhonglei, Ms. Wang Dongmei and two nominees of Tencent, namely Mr. Lau Seng Yee and Mr. Lin Haifeng, to be appointed as executive Directors. The above appointments of the Incoming Directors were approved by the Board on 5 February 2016 in accordance with the Company's Articles of Association and their appointments have taken effect from 5 February 2016. Mr. Yuen has ceased to be the chairman of the Board and the chief executive officer of the Company. The Board announced that Mr. Wang Zhongjun will be appointed as the chairman of the Board and the chief executive officer of the Company, and Mr. Lau Seng Yee will be appointed as the vice chairman of the Board. All of the aforementioned changes have taken effect from 5 February 2016. Following the resignation of Mr. Zhang Changsheng as the executive Director and vice chairman of the Company, Mr. Zhang Changsheng has ceased to be a member of the executive committee of the Company and the strategic committee of the Company. Mr. Yuen has also ceased to be the chairman of the Executive Committee; the Strategic Committee; the nomination committee of the Company; and the corporation governance committee of the Company, and a member of the remuneration committee of the Company. The Board announced that Mr. Wang Zhongjun has been appointed as the chairman of the Executive Committee; the Strategic Committee; the Corporate Governance Committee; and the Nomination Committee and a member of the Remuneration Committee. The Board further announced that Mr. Lau Seng Yee has been appointed as a member of the
Executive Committee and the Strategic Committee. Mr. Zhang Changsheng ceased to be an authorised representative of the Company under Rule 3.05
of the Listing Rules and Mr. Wang Zhonglei has been appointed as an Authorized Representative, both with effect from 5 February 2016.